Welcome!
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care.  Combining an experienced product development team and a growing portfolio of innovative drug delivery technologies, Oriel is focused on delivering compelling patient options for the treatment of asthma and COPD. 



News

Oriel Therapeutics, Inc. - receives 4th US Patent
For Immediate Release Read Full Article

Oriel $23 million richer: firm brings new chairman
Triangle Business Journal - November 19, 2007 Team of investors optimistic about company's inhaler technology Triangle Business Journal - by Frank Vinluan Read Full Article